All Articles

For millions with back pain, diagnosis is a guess. Aclarion's AI platform promises a 97% success rate, and it's expanding with a key Indiana partnership.

Cloud Range's latest move signals a market shift from mere practice to provable performance, arming leaders with the data needed to validate cyber resilience.

Founder Remy Trafelet returns as CEO of Hazeltree, joined by new operations and product chiefs to accelerate AI integration and solidify its market lead.

Alif Semiconductor's licensing of Arm Keil MDK is more than a software deal; it's a strategic move to tame fragmentation and accelerate the next wave of tinyML.

Q2 Metals' appointment of a seasoned lithium executive signals a crucial shift from discovery to development for its massive Cisco project in Québec.

Shoals Technologies posts a 47% revenue surge and a record $801M backlog, yet shrinking profits reveal the immense operational friction of wiring the energy transition.

A new partnership signals a major shift in U.S. space defense, where on-demand orbital logistics and startup innovation are the ultimate strategic assets.

LivePerson's urgent call for a 'FOR' vote on its SoundHound AI merger is more than corporate messaging—it's a plea for survival, revealing a high-stakes network play.

Oblenio Bio's LBL-051 enters human trials, offering hope for a true "immune reset" and drug-free remission for severe autoimmune disease patients.

By partnering with major CROs, Revolune is tackling a key bottleneck in advanced tissue analysis. This new ecosystem could change how labs of all sizes innovate.

As the data center boom faces fierce community opposition, one firm is betting that proactive engagement, not just PR, is the key to building our digital future.

KeyCorp's acquisition of Clearwater UK isn't just a deal; it's a strategic move to dominate the transatlantic middle-market M&A landscape. What does this mean for clients and competitors?

A new partnership between a CPG giant and a gig economy platform isn't just a marketing stunt; it's a blueprint for the future of consumer engagement.

Sage Dental's major acquisition in Tampa isn't just a deal; it's a look into the future of healthcare—a story of scale, strategy, and the test of local trust.

As firms drown in complex trade rules, a new AI solution from Descartes promises to automate compliance, maximize duty savings, and reduce costly errors.

Westlake Chemical Partners reports flat net income but a massive cash flow jump, proving its post-turnaround efficiency and fortifying its reputation for stability.

A 22% AFFO surge and record RevPAR aren't luck. Inside Chatham Lodging's Q2 success driven by strategic buys and relentless operational efficiency.

Enpro's Q2 results reveal a powerful strategy: leveraging the AI-driven semiconductor boom to deliver record growth while navigating a mixed industrial landscape.

A deep dive into Westlake's stunning Q2 turnaround, where a $600M strategic plan met global supply shocks, creating a powerful recovery amid market chaos.

TelyRx just revamped its entire platform based on patient feedback. In a market with giants like Amazon, is a bet on transparency and convenience the winning move?